Vanguard Group Inc Synaptogenix, Inc. Put Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SNPX
# of Institutions
25Shares Held
955KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny401KShares$1.65 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA154KShares$634,8750.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il83.5KShares$343,3650.0% of portfolio
-
Two Sigma Securities, LLC New York, NY83.4KShares$342,8100.0% of portfolio
-
Cannell & Co. New York, NY30KShares$123,3000.0% of portfolio
About Synaptogenix, Inc.
- Ticker SNPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 6,840,630
- Market Cap $28.1M
- Description
- Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...